US7932268 — Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side effects
Method of Use · Assigned to University of Pennsylvania Penn · Expires 2027-08-19 · 1y remaining
What this patent protects
This patent protects methods for treating hyperlipidemia and hypercholesterolemia by administering escalating doses of an MTP inhibitor.
USPTO Abstract
The present invention provides methods and compositions for treating hyperlipidemia and/or hypercholesterolemia comprising administering to the subject an effective amount of an MTP inhibitor to inhibit hyperlipidemia and/or hypercholesterolemia in said subject, wherein said administration comprises an escalating series of doses of the MTP inhibitor. In some embodiments the method comprises administering at least three step-wise, increasing dosages of the MTP inhibitor to the subject. In some embodiments, the method further comprises the administration of one or more other lipid modifying compounds.
Drugs covered by this patent
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-1316 |
— | lomitapide-mesylate |
U-1316 |
— | lomitapide-mesylate |
U-1316 |
— | lomitapide-mesylate |
U-1316 |
— | lomitapide-mesylate |
U-1316 |
— | lomitapide-mesylate |
U-1316 |
— | lomitapide-mesylate |
U-1316 |
— | lomitapide-mesylate |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.